129 related articles for article (PubMed ID: 23894774)
21. Expression of chemokine receptors, CXCR4 and CXCR5, and chemokines, BLC and SDF-1, in the eyes of patients with primary intraocular lymphoma.
Chan CC; Shen D; Hackett JJ; Buggage RR; Tuaillon N
Ophthalmology; 2003 Feb; 110(2):421-6. PubMed ID: 12578791
[TBL] [Abstract][Full Text] [Related]
22. The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients.
Lin SC; Chen KH; Lin CH; Kuo CC; Ling QD; Chan CH
Eur J Clin Invest; 2007 Dec; 37(12):987-96. PubMed ID: 18036033
[TBL] [Abstract][Full Text] [Related]
23. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
[TBL] [Abstract][Full Text] [Related]
24. Chemokine and chemokine receptor analysis reveals elevated interferon-inducible protein-10 (IP)-10/CXCL10 levels and increased number of CCR5+ and CXCR3+ CD4 T cells in synovial fluid of patients with enthesitis-related arthritis (ERA).
Aggarwal A; Agarwal S; Misra R
Clin Exp Immunol; 2007 Jun; 148(3):515-9. PubMed ID: 17374135
[TBL] [Abstract][Full Text] [Related]
25. Kinetics of chemokines in acute myocardial infarction.
Kobusiak-Prokopowicz M; Orzeszko J; Mazur G; Mysiak A; Orda A; Mazurek W
Kardiol Pol; 2005 Apr; 62(4):301-14; discussion 315-6. PubMed ID: 15928736
[TBL] [Abstract][Full Text] [Related]
26. Blood dendritic cells in systemic lupus erythematosus exhibit altered activation state and chemokine receptor function.
Gerl V; Lischka A; Panne D; Grossmann P; Berthold R; Hoyer BF; Biesen R; Bruns A; Alexander T; Jacobi A; Dörner T; Burmester GR; Radbruch A; Hiepe F
Ann Rheum Dis; 2010 Jul; 69(7):1370-7. PubMed ID: 19854711
[TBL] [Abstract][Full Text] [Related]
27. Fulvestrant (Faslodex), an estrogen selective receptor downregulator, in therapy of women with systemic lupus erythematosus. clinical, serologic, bone density, and T cell activation marker studies: a double-blind placebo-controlled trial.
Abdou NI; Rider V; Greenwell C; Li X; Kimler BF
J Rheumatol; 2008 May; 35(5):797. PubMed ID: 18381791
[TBL] [Abstract][Full Text] [Related]
28. [Expression and clinical significance of inducible co-stimulator on peripheral blood T lymphocyte subsets in patients with systemic lupus erythematosus].
Yang JH; Shen Q; Zhao DB; Cai Q; Han XH
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):318-23. PubMed ID: 15854508
[TBL] [Abstract][Full Text] [Related]
29. Expression of messenger RNA for transforming growth factor-beta1 and for transforming growth factor-beta receptors in peripheral blood of systemic lupus erythematosus patients treated with low doses of quinagolide.
Hrycek A; Kusmierz D; Dybała T; Swiatkowska L
Autoimmunity; 2007 Feb; 40(1):23-30. PubMed ID: 17364494
[TBL] [Abstract][Full Text] [Related]
30. Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers.
Rothenbacher D; Müller-Scholze S; Herder C; Koenig W; Kolb H
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):194-9. PubMed ID: 16239601
[TBL] [Abstract][Full Text] [Related]
31. Increased circulating CXCL13 levels in systemic lupus erythematosus and rheumatoid arthritis: a meta-analysis.
Bao YQ; Wang JP; Dai ZW; Mao YM; Wu J; Guo HS; Xia YR; Ye DQ
Clin Rheumatol; 2020 Jan; 39(1):281-290. PubMed ID: 31523787
[TBL] [Abstract][Full Text] [Related]
32. Polymorphisms in the promoter region of RANTES and the regulatory region of monocyte chemoattractant protein-1 among Chinese children with systemic lupus erythematosus.
Liao CH; Yao TC; Chung HT; See LC; Kuo ML; Huang JL
J Rheumatol; 2004 Oct; 31(10):2062-7. PubMed ID: 15468376
[TBL] [Abstract][Full Text] [Related]
33. Elevated production of B cell chemokine CXCL13 is correlated with systemic lupus erythematosus disease activity.
Wong CK; Wong PT; Tam LS; Li EK; Chen DP; Lam CW
J Clin Immunol; 2010 Jan; 30(1):45-52. PubMed ID: 19774453
[TBL] [Abstract][Full Text] [Related]
34. CC chemokine ligand-5 (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptoms.
Kraaijeveld AO; de Jager SC; de Jager WJ; Prakken BJ; McColl SR; Haspels I; Putter H; van Berkel TJ; Nagelkerken L; Jukema JW; Biessen EA
Circulation; 2007 Oct; 116(17):1931-41. PubMed ID: 17909104
[TBL] [Abstract][Full Text] [Related]
35. CXCL13, CCL4, and sTNFR as circulating inflammatory cytokine markers in primary and SLE-related autoimmune hemolytic anemia.
Wu B; Wang W; Zhan Y; Li F; Zou S; Sun L; Cheng Y
J Transl Med; 2015 Apr; 13():112. PubMed ID: 25889297
[TBL] [Abstract][Full Text] [Related]
36. Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice.
Wareing MD; Lyon AB; Lu B; Gerard C; Sarawar SR
J Leukoc Biol; 2004 Oct; 76(4):886-95. PubMed ID: 15240757
[TBL] [Abstract][Full Text] [Related]
37. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus.
Yang JH; Zhang J; Cai Q; Zhao DB; Wang J; Guo PE; Liu L; Han XH; Shen Q
Rheumatology (Oxford); 2005 Oct; 44(10):1245-54. PubMed ID: 15987711
[TBL] [Abstract][Full Text] [Related]
38. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
Blanco P; Pitard V; Viallard JF; Taupin JL; Pellegrin JL; Moreau JF
Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052
[TBL] [Abstract][Full Text] [Related]
39. The role of chemokines in exercise-induced bronchoconstriction in asthma.
Tahan F; Karaaslan C; Aslan A; Kiper N; Kalayci O
Ann Allergy Asthma Immunol; 2006 Jun; 96(6):819-25. PubMed ID: 16802769
[TBL] [Abstract][Full Text] [Related]
40. Selected acute phase proteins and interleukin-6 in systemic lupus erythematosus patients treated with low doses of quinagolide.
Hrycek A; Pochopień-Kenig G; Scieszka J
Autoimmunity; 2007 May; 40(3):217-22. PubMed ID: 17453721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]